期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 130, 期 -, 页码 71-81出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2018.10.429
关键词
Cold atmospheric plasma; Reactive species; Iron oxide-based; Magnetic nanoparticles; Epidermal growth factor receptor; Lung cancer treatment
资金
- National Natural Science Foundation of China, China [81774125]
- Natural Science Foundation of Shandong Province, China [ZR2015HL064]
- National Science Foundation, USA [1465061]
Cold atmospheric plasma (CAP) is an emerging biomedical technique that shows great potential for cancer treatment. On the other hand, magnetic nanoparticles open up a wide field of possible applications in medicine. Here we seek to develop a novel dual cancer therapeutic method by integrating promising CAP and iron oxide-based magnetic nanoparticles (MNPs), and evaluate its underlying mechanism for targeted lung cancer treatment. For this purpose, the synergistic effects of CAP and iron oxide-based MNPs on cellular bioactivity, epidermal growth factor receptor (EGFR) expression, and EGFR downstream signaling pathways were investigated. Results showed that the effectiveness of CAP and iron oxide-based MNPs for synergistic strongly killed activity against lung cancer cells, and significantly inhibited cell proliferation via reduction of viability and induction of apoptosis. Importantly, CAP combining with iron oxide-based MNPs induced EGFR downregulation while CAP inhibited lung cancer cells via depressing pERK and pAKT. Translation of these findings to an in vivo setting demonstrates that CAP combining iron oxide-based MNPs is effective at preventing xenograft tumors. Thus, the integration of CAP and iron oxide-based MNPs provides a promising tool for the development of a new cancer treatment strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据